InvestorsHub Logo

drugrunner

03/26/20 1:04 PM

#273326 RE: JRIII #273322

pats on the back to JR3

most people believed the overall trial may not be stat sig but the subgroups definitely point to specialized targeted medicine and nwbo being at the forefront of this movement.

many are hopeful the fda approves based on this